Sylvain Fanier has devoted his career to overseeing and leading the development of several global medical innovations in the health sector. He brings to the company his leadership in strategy, a global perspective of business and financing, acquired over the past 30 years in large groups such as Johnson and Johnson and CR Bard and in medical startups. Specializing in breakthrough medical innovation, he has supported the success of innovative companies such as Lemerpax, Cardioinsight, Sonoscanner, Soundbite Medical Solutions, Surgivisio and Med-Innov through his consulting company, Novariver.
He obtained a bachelor degree in biochemistry and a master’s degree in biology option physiology at Paul Sabatier University, Toulouse. He also holds an EMBA from ESSEC, Paris, France.
Sylvain is a director of the board of Soundbite Medical Solutions Inc. (Montreal, Canada), and Surgivisio SAS (Grenoble, France).